Immix Biopharma, Inc.
IMMXCIK 0001873835 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Mar 27, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0071
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Immix Biopharma, Inc.
| Name | Roles | Filings |
|---|---|---|
| Adams Helen C. | Director | 6 |
| Buchan Jane | Director | 6 |
| Chudnovsky Yekaterina | Director10% Owner | 4 |
| Chang Nancy T | Director | 2 |
Showing 6-9 of 9
PrevPage 2 of 2
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Immix Biopharma, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Marquet Magda | 3 | 100% | +120.4% | +105.6% | +150.2% | +105.3% |
| 2 | Morris Gabriel S | 6 | 67% | +41.5% | +8.1% | +210.3% | -16.3% |
| 3 | Rachman Ilya M | 6 | 67% | +40.3% | +8.1% | +203.1% | -16.3% |
| 4 | Hsu Jason | 13 | 38% | +16.1% | -16.5% | +112.7% | -33.3% |
All filings
68 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|